PMA device
Amplatzer Piccolo Occluder
Abbott Medical · Occluder, Patent Ductus, Arteriosus (MAE, Class III) · First FDA decision Jan 11, 2019, newest Mar 27, 2023Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
4
Naming "Amplatzer Piccolo"
MAUDE reports
330
Brand "Amplatzer Piccolo", since 2015
PubMed studies
38
Mentioning "Amplatzer Piccolo"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Amplatzer Piccolo Occluder
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Amplatzer Piccolo OccluderPMA supplement
P020024-S067 · Decided Mar 27, 2023 · 143 days after receipt · Normal 180 Day Track No User Fee
Device type: OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Amplatzer Piccolo", any status and sponsor, newest update first.
- Abbott Structural Heart Device RegistryRecruiting
Abbott Medical DevicesPublic (ABT)
NCT06590467 · 2,500 participants (planned) · Start Aug 21, 2024 · Primary completion Dec 2029
Device: Amplatzer™ Occlusion Devices; Epic™ Surgical Tissue Heart Valve devices · For: Heart Diseases; ASD - Atrial Septal Defect; VSD - Muscular Ventricular Septal Defect and 3 more
Sites: Los Angeles, California; Washington D.C., District of Columbia; Miami, Florida · 36 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Amplatzer Piccolo", and for the whole product code for context.
This brand
330 reports: 50 malfunction, 240 injury, 40 death
Whole product code MAE
989 reports: 371 malfunction, 557 injury, 61 death
Newest reports for this brand
- Amplatzer PiccoloInjury
2135147-2026-07213 · Received Oct 26, 2026 · Event dated Jan 1, 2019
Device type: Occluder, Patent Ductus, Arteriosus (MAE)
Device problem as coded: Migration or Expulsion of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2192-2008 · Started Apr 25, 2008 · Posted by FDA Sep 3, 2008
Reason given: AGA Medical Corporation has identified an issue with outer pouch seal integrity within one production lot of 10 French 45/80 delivery systems and one lot of 24 mm Sizing Balloon. We have not observed incomplete seals with the inner pouch. An intact inner pouch seal will maintain device sterility. AGA is asking that...
Cause as FDA categorized it: Packaging process control
4 more recall records with a free account
Published research
The most relevant PubMed records for "Amplatzer Piccolo"[tiab]. The summary above synthesizes these.
- Aortic migration of Amplatzer Piccoloࡊ ductal Occluder.
Minocha PK, Sutton N, Crawford MT, et al. · Cardiol Young · 2022Case Reports
- Piccolo in transcatheter PDA closure multi-centre study from premature to adolescent children.
Baspinar O, Narin N, Baykan A, et al. · Cardiol Young · 2024Multicenter Study
- Off-label uses of the Amplatzer Piccolo Occluder in children with congenital and acquired heart diseases.
Molloy A, Tailor N, Naik R, et al. · Future Cardiol · 2024
- Institutional Trend in Device Selection for Transcatheter PDA Closure in Premature Infants.
Guyon P, Duster N, Katheria A, et al. · Pediatr Cardiol · 2022
- Transjugular venous approach for Piccolo patent ductus arteriosus closure in a 1.4 kg infant.
Herron C, Forbes TJ, Kobayashi D · Cardiol Young · 2022
- Left Pulmonary Artery Occlusion Following Device Closure of Patent Ductus Arteriosus in Premature Infants.
Jaile JC, Siwik E, Bartakian S · J Soc Cardiovasc Angiogr Interv · 2024
- Device Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants.
Baruteau AE, Méot M, Benbrik N, et al. · JACC Adv · 2024Review
- Advances in Pediatric Ductal Intervention: an Open or Shut Case?
Eilers L, Qureshi AM · Curr Cardiol Rep · 2020Review
- Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ࣙ700 grams.
Sathanandam SK, Gutfinger D, O'Brien L, et al. · Catheter Cardiovasc Interv · 2020Clinical Trial, Multicenter Study
- Piccolo Device for Treating Patent Ductus Arteriosus Beyond Premature Newborn Patients, a Novel Experience in South America: A Retrospective Study.
Aristizabal AM, Olave I, Guzmán-Serrano CA, et al. · Health Sci Rep · 2025
- Utility of the Amplatzer Piccoloࡊ occluder in the endovascular treatment of pulmonary sequestration in infants.
Santiago J, Alvarado J, Guarin M, et al. · An Pediatr (Engl Ed) · 2024Case Reports
- The Transcatheter Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants: Technique and Results.
Baruteau AE, Fraisse A, Butera G, et al. · J Cardiovasc Dev Dis · 2023Review
Other devices of this type
Also filed under product code MAE.
- Amplatzer Duct Occluder, Amplatzer Duct Occluder II, Amplatzer Piccolo OccluderAbbott Medical · PMA 2024
- Amplatzer Septal Occluder,cribriform Ocluder,and Delivery and Exchange SystemsAbbott Medical · PMA 2016
- Nit-Occlud PdaPfm Medical, Inc. · PMA 2024
- Pma Nit-Occlud PdaPfm Medical, Inc. · PMA 2016
- Amplatzer Septal Defect OccluderAbbott Medical · PMA 2015
- Amplatzer Multi-Fenestrated Septal Occluder ? ?cribriform? OccluderAbbott Medical · PMA 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.